GL1X · GenesisL1 explorer

Research workbench

Oxalyl-aryl-amino benzoic acid inhibitors of PTP1B, compound 17

Analyse Oxalyl-aryl-amino benzoic acid inhibitors of PTP1B, compound 17 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1ONY
Type
protein
Length
282 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein-tyrosine phosphatase, non-receptor type 1
EC
3.1.3.48
UniProt
P18031
Ligands
588
Pockets
1 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein-tyrosine phosphatase, non-receptor type 1 (EC 3.1.3.48)protein28236% helix, 21% strandP18031

Ligands and binding sites

  • 588 · 2-{[2-(2-carbamoyl-vinyl)-4-(2-methanesulfonylamino-2-pentylcarbamoyl-ethyl)-phenyl]-oxalyl-amino}-benzoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11400.450.7624588

Compared structures

  • 1ONY · Oxalyl-Aryl-Amino Benzoic Acid inhibitors of PTP1B, compound 17 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.